Skip to content

The Role of Lumbar Multifidus Characteristics in the Development of Low Back Pain

The Role of Lumbar Multifidus Characteristics in the Development of Low Back Pain

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03387930
Enrollment
140
Registered
2018-01-02
Start date
2017-08-01
Completion date
2022-06-30
Last updated
2021-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Keywords

Low back pain, lumbar multifidus, Proprioception, Elastography, Magnetic resonance imaging

Brief summary

Low back pain (LBP) is a severe epidemic in the world. Despite its high prevalence, 90% of the cases have no identifiable cause. Approximately 44% of them experience recurrent LBP within one year and 10% of them develop chronic LBP that lasts for three months or more. Mechanically, the lumbar spine is unstable and requires spinal muscle to maintain spinal stability and to prevent injuries. Lumbar multifidus (LM) muscle is thought to be the major spinal stabilizer responsible for spinal stability and spinal proprioception. Prior studies have revealed that increased fat infiltration, atrophy or activation deficits of LM in patients with LBP as compared to asymptomatic individuals. Unfortunately, inconsistent findings have also been reported. Although prior research attempted to determine if abnormal LM characteristics can inform clinical decision-making, their results are limited because they only investigated a single LM characteristic at a time, which might not reflect the actual LM condition. Further, many studies adopted cross-sectional design that could not reveal the casual relations between abnormal LM characteristics and LBP. As such, the current study aims to identify specific LM characteristics that can predict new episode of LBP in asymptomatic individuals, and recurrent/chronic LBP in individuals with LBP at baseline.

Detailed description

Low back pain (LBP) is a severe epidemic in the world. Despite its high prevalence, 90% of the cases have no identifiable cause. While most people with LBP recover shortly after onset, approximately 44% of them experience recurrent LBP within one year and 10% of them develop chronic LBP that lasts for three months or more. Mechanically, the lumbar spine is unstable and requires spinal muscle to maintain spinal stability and to prevent injuries. Lumbar multifidus (LM) muscle is thought to be the major spinal stabilizer responsible for spinal stability and spinal proprioception. Different cross-sectional studies have revealed that increased fat infiltration, atrophy or activation deficits of LM in patients with LBP as compared to asymptomatic individuals. Research has shown that abnormal morphology or activation of LM is associated with LBP intensity/location, or LBP-related disability. Unfortunately, inconsistent findings have also been reported. Although prior research attempted to determine if abnormal LM characteristics can inform clinical decision-making, their results are limited because they only investigated a single LM characteristic at a time, which might not reflect the actual LM condition. Further, many studies adopted cross-sectional design that could not reveal the casual relations between abnormal LM characteristics and LBP. Given the above, the current study aims to identify specific LM characteristics that can predict new episode of LBP in asymptomatic individuals, and recurrent/chronic LBP in individuals with LBP at baseline.

Interventions

None listed

Sponsors

University of Oulu
CollaboratorOTHER
The University of Hong Kong
CollaboratorOTHER
Rush University
CollaboratorOTHER
Concordia University, Montreal
CollaboratorOTHER
Zurich University of Applied Sciences
CollaboratorOTHER
The Hong Kong Polytechnic University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* aged 18 to 65 years * Symptomatic participants should have LBP that requires medical consultation(s) in the last three months * LBP intensity of at least 5 on the 11-point numeric pain rating scale at baseline (for symptomatic participants) * Asymptomatic participants should be pain free at baseline, and should not have LBP in the last year nor LBP lasting more than a week in the last 3 years

Exclusion criteria

* a history of neurological disease or vestibular impairment * systemic inflammatory disease * prior spinal surgery * acute/chronic neuropathy or radiculopathy * spinal infections/fractures/tumors, metabolic disorders, * medical 'red flags'

Design outcomes

Primary

MeasureTime frameDescription
11-point numeric pain rating scale (NPRS) for low back pain2 yearsThe current pain intensity of each participant will be quantified by an 11-point NPRS, where 0 means no pain and 10 means the worst imaginable pain.

Secondary

MeasureTime frameDescription
Proprioception of lumbar multifidus2 yearsAn established protocol to measure proprioception of lumbar multifidus
Morphometry of lumbar multifidus2 yearsB-mode ultrasound imaging will be used to quantify morphometry of multifidus
Stiffness of lumbar multifidus2 yearsElastography will be used to measure lumbar multifidus stiffness
Fatty infiltration of lumbar multifidus2 yearsMagnetic resonance imaging will be used to quantify the fatty infiltration of multifidus

Countries

Hong Kong

Contacts

Primary ContactArnold Wong, PhD
arnold.wong@polyu.edu.hk852-2766-6741

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026